DERMAPHARM HOLDING SE (DMP.DE) Stock Overview
Europe - FRA:DMP - DE000A2GS5D8 - Common Stock
DMP.DE Key Statistics, Chart & Performance
The current stock price of DMP.DE is 32 EUR. In the past month the price decreased by -6.28%. In the past year, price decreased by -8.29%.
DMP.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 47.06 | 609.71B | ||
| LLY.DE | ELI LILLY & CO | 46.21 | 598.73B | ||
| ZEG.DE | ASTRAZENECA PLC | 17.27 | 401.05B | ||
| JNJ.DE | JOHNSON & JOHNSON | 17.67 | 360.77B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.12 | 240.51B | ||
| NOV.DE | NOVO NORDISK A/S-B | 15.02 | 222.97B | ||
| NOT.DE | NOVARTIS AG-REG | 14.09 | 202.18B | ||
| 1SAN.MI | SANOFI | 10.63 | 195.68B | ||
| SAN.PA | SANOFI | 10.55 | 194.24B | ||
| SNW.DE | SANOFI | 10.52 | 193.68B | ||
| 1MRKX.MI | MERCK & CO. INC. | 10.58 | 172.60B | ||
| 6MK.DE | MERCK & CO. INC. | 10.44 | 170.35B |
Related stock screener links
About DMP.DE
Company Profile
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company is headquartered in Gruenwald, Bayern and currently employs 3,551 full-time employees. The company went IPO on 2018-02-09. The firm operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. The company holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The firm offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. The company is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Company Info
DERMAPHARM HOLDING SE
Lil-Dagover-Ring 7
Gruenwald BAYERN DE
Employees: 3610
Phone: 4989641860
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the stock price of DERMAPHARM HOLDING SE today?
The current stock price of DMP.DE is 32 EUR. The price decreased by -0.31% in the last trading session.
What is the ticker symbol for DERMAPHARM HOLDING SE stock?
The exchange symbol of DERMAPHARM HOLDING SE is DMP and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is DMP.DE stock listed?
DMP.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for DERMAPHARM HOLDING SE stock?
11 analysts have analysed DMP.DE and the average price target is 43.25 EUR. This implies a price increase of 35.15% is expected in the next year compared to the current price of 32. Check the DERMAPHARM HOLDING SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DERMAPHARM HOLDING SE worth?
DERMAPHARM HOLDING SE (DMP.DE) has a market capitalization of 1.72B EUR. This makes DMP.DE a Small Cap stock.
How many employees does DERMAPHARM HOLDING SE have?
DERMAPHARM HOLDING SE (DMP.DE) currently has 3610 employees.
What are the support and resistance levels for DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a support level at 31.3 and a resistance level at 32.15. Check the full technical report for a detailed analysis of DMP.DE support and resistance levels.
Is DERMAPHARM HOLDING SE (DMP.DE) expected to grow?
The Revenue of DERMAPHARM HOLDING SE (DMP.DE) is expected to decline by -0.58% in the next year. Check the estimates tab for more information on the DMP.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DERMAPHARM HOLDING SE (DMP.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DMP.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DMP.DE, evaluating the profitability, health, valuation and growth aspects
- DERMAPHARM HOLDING SE (DMP.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DERMAPHARM HOLDING SE (DMP.DE) Sales and EPS estimates to see what analysts future expectations are.
- DERMAPHARM HOLDING SE (DMP.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DERMAPHARM HOLDING SE (DMP.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- DERMAPHARM HOLDING SE (DMP.DE) Stock Chart to make your own analysis
- DERMAPHARM HOLDING SE (DMP.DE) Latest news and press-releases to stay up to date.
Does DERMAPHARM HOLDING SE (DMP.DE) stock pay dividends?
DERMAPHARM HOLDING SE (DMP.DE) has a dividend yield of 2.75%. The yearly dividend amount is currently 0.88. Check the full fundamental report for a detailed analysis of DMP.DE dividend history, reliability and sustainability.
When does DERMAPHARM HOLDING SE (DMP.DE) report earnings?
DERMAPHARM HOLDING SE (DMP.DE) will report earnings on 2025-11-13.
What is the Price/Earnings (PE) ratio of DERMAPHARM HOLDING SE (DMP.DE)?
The PE ratio for DERMAPHARM HOLDING SE (DMP.DE) is 16.08. This is based on the reported non-GAAP earnings per share of 1.99 and the current share price of 32 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DMP.DE.
DMP.DE Technical Analysis
DMP.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE. There are concerns on the financial health of DMP.DE while its profitability can be described as average.
DMP.DE Financial Highlights
Over the last trailing twelve months DMP.DE reported a non-GAAP Earnings per Share(EPS) of 1.99. The EPS increased by 29.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.11% | ||
| ROA | 5.02% | ||
| ROE | 17.62% | ||
| Debt/Equity | 1.52 |
DMP.DE Forecast & Estimates
11 analysts have analysed DMP.DE and the average price target is 43.25 EUR. This implies a price increase of 35.15% is expected in the next year compared to the current price of 32.
For the next year, analysts expect an EPS growth of 13.74% and a revenue growth -0.58% for DMP.DE